Delaware Bioscience Association President Michael Fleming takes a 30,000 foot-view of innovation and the First State's role as a catalyst.
Title: President Workplace: Delaware BioScience Association Alma Maters: University of Delaware, John Hopkins University Boards: Delaware Technology Park, ChristianaCare’s Gene Editing Institute, Council of State Bioscience Associations Q&A: Best advice […]
Henry Kissinger passed away Nov. 29 at age 100, a singular, domineering figure in the conduct of our country’s foreign policy. Controversial and polarizing, Kissinger was celebrated and highly regarded […]
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
Already home to a major AstraZeneca plant and others, Delaware is preparing for a rush of biopharmaceutical manufacturing jobs.
In late October, the National Assessment of Educational Progress (NAEP), known since its founding in the early 1990s as “the Nation’s Report Card,” revealed that math scores of the country’s […]
NEWARK – As life science companies have grown organically and been attracted to the First State in the past few years, it’s created a new challenge for the local labor […]
The U.S. Attorney General recently announced arrests and charges associated with multiple schemes tied to the Chinese government’s “relentless campaign to gain access to our technology.” This multi-year effort is […]
In July, more than 40 foreign ambassadors traveled from their embassy posts in Washington, D.C., to spend the day in Delaware. This was a remarkable, historic thing for our small […]
People on the Move is a rundown of recent hirings, promotions, appointments and other notable movements by professionals in the state. If you’re interested in submitting an entry, please contact news@delawarebusinesstimes.com. […]
WILMINGTON – A new report released Wednesday highlights the growing investment in life sciences, including biopharmaceutical, research and development, medical technology, agriculture and manufacturing, in Delaware over the last decade. […]
WILMINGTON – Leaders of four of Delaware’s largest business organizations recently signed onto a regional letter voicing opposition to a bill proposed in Congress that would dramatically alter how prescription […]
In Delaware, policymakers, high-profile entrepreneurs and top-notch researchers are just a phone call away As a place for doing business, Delaware’s “enormous benefit” is that it is … small. So […]
MIDDLETOWN – A fast-growing Chinese pharmaceutical company seeking to land its first major American manufacturing site has been identified as the until-now codenamed mega prospect “Project Dragonfly” looking at nearly […]
President Joe Biden was spot on when he told Congress last week that continued investment in research and development is essential to our country’s global leadership and economic security. Fortunately, […]
DOVER – With the First State home to bioscience giants like AstraZeneca and Incyte, and a growing number of successful startups like Prelude Therapeutics, a group of state legislators are […]
WILMINGTON – The Delaware BioScience Association has unveiled a new website, including a fresh, vibrant look and members-only digital portal that will accelerate its mission to grow the state’s thriving life […]
By Michael Fleming Guest Columnist As the COVID-19 vaccine begins to be rolled out with our front-line health care workers and those most at risk in Delaware and across the […]
By Michael Fleming The extraordinarily successful initial public offering by Prelude Therapeutics (PRLD) last month made clear investors’ immense confidence in prospects for the Wilmington biopharmaceutical company. Prelude’s market capitalization […]
WILMINGTON – Delaware BioScience Association has named Michael Fleming as its next president, succeeding Helen Stimson who left the organization this month for a role at Adesis Inc. Delaware Bio […]
© 2024 Delaware Business Times